What Anhui Medipharm Co. does

Anhui Medipharm Co., Ltd. is a privately held Chinese pharmaceutical exporter founded in 2010 and headquartered in Hefei, Anhui Province. The company supplies four product categories — generic medicines (tablets, capsules, powder injections, water injections, IV solutions, and suspensions), medical products (surgical sutures, wound dressings, examination gloves, syringes, IV cannulas, and diagnostic tests), veterinary drugs, and active pharmaceutical ingredients (APIs) and intermediates — to distributors, pharmacies, hospitals, and healthcare ministries across more than 80 countries in Asia, Africa, South America, the Middle East, and Europe. Its portfolio spans antibiotics (penicillins, cephalosporins, fluoroquinolones, carbapenems), antimalarials, antiprotozoals, and basic surgical and wound-care consumables, with individual SKUs carrying GMP, ISO 13485, CE, BP, USP, COPP, and CTD certifications.

The company operates a B2B, sales-led go-to-market model built around international trade exhibitions (CPHI China, Canton Fair) and a multilingual website (English, French, Spanish, Arabic, Simplified Chinese). It supports OEM/ODM customization for market-specific requirements and offers FOB and CIF trade terms with T/T and L/C payment. Core technology is not publicly disclosed, and the company's competitive positioning rests on breadth of catalog, regulatory certifications, multi-geography distribution reach, and 15 years of operating history rather than on proprietary technology or AI. Revenue, headcount expansion, and ownership structure are not publicly disclosed; leadership is referenced only as President Zhang.

Name

Anhui Medipharm Co.

Legal name

Anhui Medipharm Co., Ltd.

Website

https://medipharm.cn

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

11–50 employees

Short description

Anhui Medipharm Co. is a China-based pharmaceutical exporter founded in 2010 that supplies generic medicines, APIs, medical consumables, and veterinary drugs to distributors, pharmacies, hospitals, and health ministries across 80+ countries, supported by GMP, ISO, and CE certifications.

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals

NAICS

Pharmaceutical and Medicine Manufacturing (3254), Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Pharmaceutical Preparations (2834), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Generic Finished Dosage Form (FDF) Manufacturing (HLAIABAH)

akta.pro secondary industries

Compounding Ingredient & API Distributors (Pharma Supply) (HLAIAJAO), Medical, Dental & Lab Supply Marketplaces (CRAFAHAG), Government & Public-Sector Pharmaceutical Supply (Tender/Prime Vendor) (HLAIAJAF)

Keywords

• Generic medicines supplier
• Active pharmaceutical ingredients
• Medical consumables export
• Pharmaceutical contract manufacturing
• Veterinary drug export

Headquarters

HQ city

Hefei

HQ country

China

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Pharmaceutical Product Sales: Anhui Medipharm generates revenue through the sale of generic medicines, APIs (Active Pharmaceutical Ingredients), medical products, and veterinary drugs to international buyers. Products include tablets, capsules, powder injections, water injections, IV solutions, suspensions & syrups, medical consumables, surgical sutures, and bandages. The company operates on an export model, supplying products to distributors, pharmacies, hospitals, and healthcare ministries across 80+ countries.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

Anhui Medipharm Co., Ltd. is a Chinese pharmaceutical products manufacturer and exporter established in 2010, supplying generic medicines (tablets, capsules, injections, IV solutions, suspensions and syrups), medical consumables and devices (sutures, dressings, syringes, gloves, IV sets), veterinary drugs, and active pharmaceutical ingredients (APIs) and intermediates. The company operates an export-led B2B model, selling directly to international distributors, pharmacies, hospitals and healthcare ministries in more than 80 countries across Asia, Africa, South America, the Middle East and Europe, and supports OEM/ODM production for market-specific requirements.

Product overview

Anhui Medipharm Co., Ltd. is a professional pharmaceutical products supplier based in China with over 15 years of experience exporting western medicines, APIs, intermediates, and medical products. The company operates four main product categories: Generic Medicines (including tablets, capsules, powder injections, water injections, IV solutions, suspensions & syrups), Medical Products (including surgical sutures, wound care dressings, examination gloves, syringes, diagnostic tests, and IV administration devices), Veterinary Drugs (multivitamin supplements for livestock), and APIs & Intermediates (active pharmaceutical ingredients). The product portfolio includes antibiotics (penicillins, cephalosporins, fluoroquinolones), antimalarials, antiprotozoals, surgical supplies, and medical consumables. Products are exported to over 80 countries across Asia, Africa, South America, Middle East, and Europe.

Differentiator

Problem solved

Functional benefit

Products and services

• Generic Medicines Generic pharmaceutical finished dosage forms including tablets, capsules, powder injections, water injections, IV solutions, suspensions and syrups. Product range covers antibiotics (penicillins, cephalosporins, fluoroquinolones, macrolides), antimalarials, antiprotozoals, anti-inflammatory and analgesic products, sold to international distributors, pharmacies, hospitals and healthcare ministries.
• Medical Products Medical consumables, surgical supplies, diagnostic and treatment equipment, medical dressings, and health/rehabilitation supplies including surgical sutures, gauze swabs and bandages, zinc oxide plasters, vaseline gauze, examination and surgical gloves, syringes, scalp vein sets, IV cannulas, urine bags, elastic bandages, cotton wool and HCG pregnancy tests. Supplied to hospitals, clinics and distributors in 80+ countries.
• Veterinary Drugs

Quantifiable outcome

• Products exported to more than 80 countries
• +1 more outcomes

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Apeloa Pharmaceutical: Zhejiang-headquartered Chinese manufacturer of APIs and finished generic dosage forms (oral and injectable) with significant export orientation. Directly comparable in product categories, manufacturing-plus-export model, and target emerging-market geographies.
• Zhejiang Huahai Pharmaceutical: China-based API and generic finished-dose manufacturer with extensive international exports (US, Europe, emerging markets). Comparable as a vertically integrated Chinese generic/API producer serving regulated and semi-regulated markets.
• Yiling Pharmaceutical: Chinese manufacturer of generic chemical drugs, APIs, and traditional Chinese medicines with a multi-category export footprint. Comparable in being a Chinese-origin multi-line generic exporter targeting international distributors and ministries.
• Tianjin Tianyao Pharmaceuticals: Chinese generic drug manufacturer producing antibiotics, injectables, and oral dosage forms with established international export operations. Comparable in therapeutic categories and export-led GTM motion.
• Hainan Poly Pharm: China-based manufacturer of generic finished dosage forms (oral solids, injectables) with active export to Southeast Asia, Africa, and Latin America. Closely comparable in product formats, manufacturing scale, and target geographies.

Broad incumbents

• CSPC Pharmaceutical Group: Large Hong Kong-listed Chinese pharmaceutical company producing APIs, generics, and innovative drugs with significant export operations. Comparable product mix but at much greater scale and with deeper regulated-market penetration.
• Livzon Pharmaceutical Group: Diversified Chinese pharma manufacturer with API, generic, and biologic product lines plus an active export business. Comparable across the generic and API categories, though substantially larger and more diversified than Anhui Medipharm.
• China Resources Pharmaceutical Group: State-owned Chinese pharmaceutical conglomerate covering generic manufacturing, distribution, and retail pharmacy. Comparable in product categories, though operating at substantially greater scale across both domestic and international channels.
• Sinopharm Group: China's largest state-owned pharmaceutical distributor with deep API and finished-dose sourcing as well as international trade operations. Comparable in the distribution/export dimension, but vastly larger and government-affiliated.
• Shanghai Pharmaceuticals Holding: Major Chinese pharmaceutical manufacturer and distributor with significant international operations and a broad generic drug portfolio. Comparable in scale of generic product range, though far larger and more diversified.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/100083651713860
• LinkedInlinkedin.com/company/anhui-medipharm-co-.ltd

Compliance10 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Anhui Medipharm Co.